Advertisement

Topics

Proteostasis Files Investigational New Drug Application For PTI-808, Cystic Fibrosis Potentiator

20:00 EDT 22 Jun 2017 | BioSpace

CAMBRIDGE, Mass., June 23, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis (CF), today announced that the Company has filed...

Original Article: Proteostasis Files Investigational New Drug Application For PTI-808, Cystic Fibrosis Potentiator

NEXT ARTICLE

More From BioPortfolio on "Proteostasis Files Investigational New Drug Application For PTI-808, Cystic Fibrosis Potentiator"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...